Medication in Childhood Epilepsy: What a Scoping Review Found
This explainer reviews medication in childhood epilepsy across self-limited focal epilepsy syndromes.
Source: Epilepsia
Summary
What was studied
This scoping review examined the use, effectiveness, safety, and stopping of antiseizure medications in children with self-limited focal epilepsies. Researchers searched nine databases through January 2026 and included 62 studies, including 11 randomized controlled trials.
Most research concerned self-limited epilepsy with centrotemporal spikes (SeLECTS; 6,171 participants). Much smaller groups had self-limited epilepsy with autonomic seizures (SeLEAS; 348), childhood occipital visual epilepsy (COVE; 91), or photosensitive occipital lobe epilepsy (POLE; 26).
What they found
In SeLECTS, reported 12-month seizure-freedom rates after medication treatment were about 72% across studies, although estimates varied considerably. Evidence for the other three syndromes was much more limited. First-line medication treatment failed in about 30% of patients. Side effects were reported in about 22% of treated children and infrequently led to stopping treatment. Randomized trials generally reported similar seizure outcomes across the medications compared, but many trials were small and open-label.
Limits of the evidence
Overall confidence in the evidence remains limited. Most studies were retrospective observational studies, looking back at previously collected information, and study methods and outcome definitions differed substantially. Evidence for SeLEAS, COVE, and POLE came mainly from small retrospective groups. Many randomized trials were small or used open-label designs, in which participants and researchers knew which treatment was given. Similar trial results do not establish that all medications work equally well. The review leaves important questions unanswered about which children need medication, how long treatment should continue, and when it can be stopped. The abstract does not define first-line treatment failure or describe specific side effects.
For families and caregivers
Children with these epilepsies often achieved seizure control with medication, and reported side effects infrequently led to treatment being stopped. However, most of the evidence concerns SeLECTS, with much less information about the other syndromes. These results do not show that every child with a self-limited focal epilepsy needs medication or establish the best treatment or stopping schedule.
What to watch next
More randomized evidence and more consistent study methods and outcome definitions could help address gaps in whether medication is needed, how long treatment should last, and when medication can be withdrawn.
Terms in this summary
- Scoping review
- A review that maps available research and identifies gaps in the evidence.
- Self-limited focal epilepsy
- An epilepsy in which seizures start in one part of the brain and are expected to stop over time.
- Randomized controlled trial
- A study that assigns participants by chance to different treatment groups.
- Retrospective study
- A study that looks back at information already collected, such as medical records.
- Open-label
- A study in which participants and researchers know which treatment is being given.
- First-line treatment
- The medication chosen as the initial treatment.
Suggest a correction ยท Editorial standards
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.